Lilly Just Announced Infectious Disease Deals Diversification
Eli Lilly is shaking up its growth plan by expanding beyond obesity with new infectious disease initiatives. This art...
A straightforward rationale for incorporating Equal Weighted Indices into a portfolio, emphasizing diversification and simplicity.
22,394 articlesEli Lilly is shaking up its growth plan by expanding beyond obesity with new infectious disease initiatives. This art...
A recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
A CFO selling NuScale stock can spark questions about the company’s outlook. This guide breaks down what the move mig...
Insider moves can shed light on a company’s trajectory, but they aren’t a crystal ball. This guide breaks down biotec...
Halozyme’s halo (HALO) 2026 earnings landscape hinges on ENHANZE collaborations, pipeline milestones, and disciplined...
Investing in early-stage biotech requires a steady playbook. This article breaks down Lantern Pharma (LTRN) in 2025, ...
As July earnings approach, investors ask if taiwan semiconductor stock before July is a smart move. This guide breaks...
As sustainability drives spending, Clean Harbors and Waste Management stand out in the industrials space. This guide ...
When a CEO sells thousands of shares, investors want to know what it signals. This guide explains how to read insider...
A CEO’s share sale at Mineralys shines a light on insider moves ahead of a key FDA event. This guide breaks down what...
As Citi gears up for its 2026 earnings call, investors need a clear view of the revenue mix, credit quality, and capi...
MannKind reported a double-digit revenue rise, but the stock still slid on Thursday. This article breaks down why the...